Skip to main content
. 2021 May 26;14(8):811–822. doi: 10.1158/1940-6207.CAPR-20-0620

Figure 1.

Figure 1. Incremental outcomes for risk stratification (based on a mean screening start age of 60), compared with screening start age of 60 for the entire population. Incremental net monetary benefit is based on a cost-effectiveness threshold of £20,000/QALY. A: Net Monetary Benefit, B: Costs, C: Quality-adjusted life years (QALYs), D: CRC incidence, E: CRC mortality, F: Use of screening colonoscopies.

Incremental outcomes for risk stratification (based on a mean screening start age of 60), compared with screening start age of 60 for the entire population. Incremental net monetary benefit is based on a cost-effectiveness threshold of £20,000/QALY. A: Net Monetary Benefit, B: Costs, C: Quality-adjusted life years (QALYs), D: CRC incidence, E: CRC mortality, F: Use of screening colonoscopies.